Ex-Cano Health CEO on Trial Amid $72M Fraud Claims

Marlow Hernandez, the founder and former CEO of Cano Health, is facing a jury trial this week over allegations that he fraudulently enriched himself and his family while managing the senior-focused primary care company. Cano filed for bankruptcy last year — an event many industry experts attributed to Hernandez’ poor governance. The post Ex-Cano Health…

Read More

BioCryst’s $700M Astria Acquisition Gives It a Shot to Beat Larger Rivals in Rare Disease HAE

BioCryst Pharmaceuticals’ Astria Therapeutics acquisition brings navenibart, a drug in Phase 3 testing for the rare disease hereditary angioedema. The injectable antibody has the potential to match the efficacy of the blockbuster Takeda Pharmaceutical drug that currently dominates the market, but with less burdensome dosing that could encourage HAE patients to switch. The post BioCryst’s…

Read More

IVF Coverage Proposals Could Squeeze U.S. Fertility Clinics Without Improving Access

Ideas floated by the Trump Administration and Democrats in Congress aim to expand access to fertility treatment as an essential health benefit. But an influx of patients could collide with an already-brittle system of 430,000 annual cycles, 5,000 embryologists, and long-overdue lab upgrades. The post IVF Coverage Proposals Could Squeeze U.S. Fertility Clinics Without Improving…

Read More

Weekend Reading

UK to pay more for pharmaceuticals?Prior distributions for regression coefficients.What is the “Rural Health Fund”Pedestrian deaths in the US (Part 1, 2)US physicians in private practice dropped from 60.1% (2012) to 42.2% (2024).

Read More

Verily Launches Free Consumer Health App to Put AI-Powered Insights in Users’ Hands

Verily has launched a free consumer health app that aggregates users’ medical records, helps them track their habits and delivers personalized preventive care recommendations. The app also features an AI-powered health assistant that contextualizes users’ data. The post Verily Launches Free Consumer Health App to Put AI-Powered Insights in Users’ Hands appeared first on MedCity…

Read More

FDA Unveils First 9 Picks for Pilot Program Speeding Up Review of ‘National Priority’ Products

Drugs selected for the FDA’s new Commissioner’s National Priority Review Voucher pilot program could receive a regulatory decision in two months or less. Qualifying product candidates must address a national priority, such as filling an unmet medical need or boosting domestic drug manufacturing. The post FDA Unveils First 9 Picks for Pilot Program Speeding Up…

Read More